Business Overview 2006 - Synthes

Synthes. Annual Report 2006
Company Profile
Synthes is a leading global medical device company. We develop, produce
and market instruments, implants and biomaterials for the surgical
fixation, correction and regeneration of the human skeleton and
its soft tissues. We are represented on every continent and employ
approximately 8,500 people worldwide. We generate revenues of
over US$ 2.3 billion and make a net profit of US$ 509 million.
Synthes establishes the foundations for its excellent market position
by continuously developing better solutions. Our goal is to provide
the safest and most advanced implants, instruments and technologies
that ensure reliable operating procedures, rapid recovery and a
pain-free life after surgery. We guarantee high quality, constant innovation
and total concentration on the needs of our customers.
Synthes is the world leader in traumatology, ranks among the top
three companies for spinal devices and is at the forefront of the craniomaxillofacial
business. We are an innovative pioneer in the field of
biomaterials such as resorbable implants and bone graft substitutes,
and have become a leader in non-fusion technologies by developing
nucleus and total intervertebral disc replacements.
Working closely together with surgeons in hospitals all over the world,
our product development teams of scientists, engineers and product
managers identify real clinical needs. This provides the basis for developing
products with increased benefits for patients, surgeons and
OR personnel.
The Functional Structure
of Global Synthes
North America
Asia Pacific Europe Latin America,
Middle East and Africa
Trauma
Spine
Cranio-maxillofacial
Biomaterials
Power Tools
Operations
Operations
Global services: Finance, Human Resources, Information Technology, Legal, Purchasing, Quality, Regulatory Affairs
1